KNOXVILLE, Tenn.--(BUSINESS WIRE)--Singapore Institute of Advanced Medicine Holdings Pte Ltd (SAM) and ProNova announced today that ProNova has been selected by SAM as its partner to establish the first proton therapy facility in Singapore. The SC360 proton therapy system will be an essential element of a new outpatient cancer center located on the Singapore Biopolis campus, an international research and development center for biomedical sciences.
Help employers find you! Check out all the jobs and post your resume.
